MLICM
INVE icon

Metropolitan Life Insurance Company (MetLife)’s Identive INVE Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio INVE Stock Details INVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,214
Closed -$7.45K – 2487
2023
Q1 		$7.45K Sell
1,214
-177
-13% -$1.3K ﹤0.01% 2240
2022
Q4 		$10.1K Sell
1,391
-3
-0.2% -$29 ﹤0.01% 2279
2022
Q3 		$17.5K Hold
1,394
– – ﹤0.01% 2088
2022
Q2 		$16.1K Hold
1,394
– – ﹤0.01% 2143
2022
Q1 		$22.5K Sell
1,394
-4,167
-75% -$80K ﹤0.01% 2031
2021
Q4 		$156K Sell
5,561
-347
-6% -$7.62K ﹤0.01% 2193
2021
Q3 		$111K Hold
5,908
– – ﹤0.01% 2471
2021
Q2 		$100K Buy
+5,908
New +$89.2K ﹤0.01% 2592

Other funds holding INVE

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
MCM
Marathon Capital Management Hunt Valley, Maryland $494M AUM 42.6% 1-Year Est. Return
JAMONY
Jacob Asset Management of New York Hermosa Beach, California $70.9M AUM 14.28% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s INVE Position: Q2 2023 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Identive (INVE) in Q2 2023, closing a stake of 1,214 shares — an estimated $7.45K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in INVE in Q2 2021 and held it in 8 quarters. The position peaked at $156K in Q4 2021. 74 funds tracked by Wall St. Rank hold INVE as of Q2 2023.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Identive position as of Q2 2023 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 1,214 Identive shares in Q2 2023, an estimated $7.45K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Identive in Q2 2021 and held it in 8 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Identive position peaked at $156K in Q4 2021.
  • 74 funds tracked by Wall St. Rank held Identive as of Q2 2023.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2023, filed 10 Aug 2023.